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Abstract: Exposure to environmental pollutants is a global
health problem and is associated with the development
of many chronic diseases, including cardiovascular disease, diabetes and metabolic syndrome. There is a growing body of evidence that nutrition can both positively and
negatively modulate the toxic effects of pollutant exposure.
Diets high in proinflammatory fats, such as linoleic acid,
can exacerbate pollutant toxicity, whereas diets rich in
bioactive and anti-inflammatory food components, including omega-3 fatty acids and polyphenols, can attenuate
toxicant-associated inflammation. Previously, researchers
have elucidated direct mechanisms of nutritional modulation, including alteration of nuclear factor kappa-lightchain-enhancer of activated B cells (NF-κB) signaling, but
recently, increased focus has been given to the ways in
which nutrition and pollutants affect epigenetics. Nutrition
has been demonstrated to modulate epigenetic markers
that have been linked either to increased disease risks or
to protection against diseases. Overnutrition (i.e. obesity)
and undernutrition (i.e. famine) have been observed to
alter prenatal epigenetic tags that may increase the risk of
offspring developing disease later in life. Conversely, bioactive food components, including curcumin, have been
shown to alter epigenetic markers that suppress the activation of NF-κB, thus reducing inflammatory responses.
Exposure to pollutants also alters epigenetic markers and
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may contribute to inflammation and disease. It has been
demonstrated that pollutants, via epigenetic modulations,
can increase the activation of NF-κB and upregulate microRNAs associated with inflammation, cardiac injury and oxidative damage. Importantly, recent evidence suggests that
nutritional components, including epigallocatechin gallate (EGCG), can protect against pollutant-induced inflammation through epigenetic regulation of p
 roinflammatory
target genes of NF-κB. Further research is needed to better
understand how nutrition can modulate pollutant toxicity
through epigenetic regulation. Therefore, the objective of
this review is to elucidate the current evidence linking epigenetic changes to pollutant-induced diseases and how this
regulation may be modulated by nutrients allowing for the
development of future personalized lifestyle interventions.
Keywords:
response;
nutrition.

anti-inflammatory nutrients; antioxidant
environmental pollutants; epigenetics;

Introduction
The levels of environmental pollutants continue to rise
worldwide, despite our increasing knowledge base of the
negative health effects of pollutant exposure. There is
increasing evidence that exposure to pollutants, including
persistent organic pollutants (POPs), heavy metals and air
pollution, can contribute to the progression of chronic
diseases such as cardiovascular disease (CVD), diabetes
and cancer. Currently, the strongest evidence linking POPs
with inflammatory diseases is related to pollutant-induced
diabetes (1, 2). Multiple meta-analyses show positive associations of exposures to POPs such as polychlorinated
biphenyls (PCBs) and pesticides with increased risk of
developing type 2 diabetes (1, 2). The health effects of pollutant exposure not only pose a problem for the individual
but also contribute to the global burden of disease.
The mechanisms by which many of these pollutants
contribute to disease involve an increase in cellular oxidative
stress and subsequent inflammatory responses. For example,
coplanar PCBs, a class of POPs, increase downstream inflammatory responses by binding to the aryl hydrocarbon receptor,
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which can upregulate the transcription of cytochrome p450
(Cyp1a1) (3, 4). Cyp1a1 is primarily involved in xenobiotic
detoxification; however, in the presence of certain PCBs, it
results in the production of reactive oxygen species (ROS) via
an uncoupling mechanism (5). This production of ROS yields
an increase in oxidative stress because of the imbalance in
the cellular redox status (4). This pro-oxidative cellular status
contributes to a state of chronic inflammation, which is a hallmark of many diseases, including atherosclerosis, diabetes
and other metabolic disorders (6).
The most common routes of exposure to these environmental pollutants are through inhalation of airborne
pollutants as well as ingestion of contaminated foods (7).
POPs, including PCBs and organochloride pesticides, are
lipophilic and therefore readily accumulate in the tissue of
living animals (8). Although the production of many of these
pollutants has been banned, their resistance to degradation
and stability in the environment have allowed for their bioaccumulation throughout the ecosystem (8). Additionally,
in humans, the accumulation of these lipophilic pollutants
over the course of many years can lead to the activation of
inflammatory pathways contributing to the development of
numerous chronic inflammatory diseases (9, 10). Obesity is
linked to higher pollutant body burden, but there is no consensus if obesity makes a person more or less susceptible
to pollutant-induced disease. Interestingly, there is some
experimental evidence that points to the sequestration of
pollutants in large adipose depots as actually being protective (11–13). Lipophilic pollutants may accumulate within
adipocytes and lipid droplets, which limits their availability to other target cell types. Importantly, it appears that
obese individuals undergoing weight loss through either
bariatric surgery or lifestyle intervention may be a highly
susceptible population to pollutant-induced inflammation
(11–13). Because overweight and obese individuals are not
only capable of accumulating greater levels of pollutants
but also already at an increased risk for developing chronic
inflammatory diseases, dietary interventions that provide a
means of combatting pollutant toxicity and chronic disease
risk factors are of great importance. (8, 14, 15).

Nutrition as a modulator of
pollutant toxicity
Poor nutrition can exacerbate the toxicity of
pollutants
It is well established that exposure to environmental pollutants can increase risk of developing chronic

inflammatory diseases, including CVD, diabetes, and
metabolic syndrome (6–9). Additionally, evidence implicates that individuals with a less nutritious or healthful
diet (i.e. rich in processed foods and low in fruits and
vegetables) are also at a greater risk of developing these
same chronic diseases (16). Common to both pollutant
exposure and poor nutrition is the activation of proinflammatory molecular proteins, including NF-κB, a key
player in the development of inflammatory responses
(17). Because of the overlap between pathways that
mediate the negative effects of poor nutrition and
environmental pollutants, there is an increasing body
of experimental evidence demonstrating that certain
nutritional components or overall nutritional status can
exacerbate the negative health effects of environmental
pollutant exposure.
Obesity is a global health problem and is a risk
factor for the development of numerous inflammatory
diseases (18). The rise in obesity is often attributed to
overconsumption of processed, nutritionally poor foods
(i.e. high energy density and low nutrient density) and
foods high in proinflammatory fats (18). It has been
consistently demonstrated that high fat diets, particularly those with greater proportions of fatty acids
coming from saturated, trans, and linoleic fatty acids
can increase inflammation and risk of CVD as well as
other metabolic complications (19, 20). In addition to
overconsumption of nutritionally poor foods, emerging
evidence now links exposure to environmental pollutants with increased adiposity and weight gain (21). Pollutants that elicit this physiological effect are termed
“obesogens” and are believed to contribute to obesity
and metabolic disorder through promotion of chronic
imbalances in lipid storage mechanisms and adipocyte
hyperplasia (21). Current evidence suggests that pollutant exposure can intensify the detrimental effects
of a proinflammatory high-fat diet (22). For example,
non-alcoholic fatty liver disease (NAFLD), commonly
seen in developed countries as a hepatic indicator of
obesity and metabolic syndrome, may be worsened by
pollutant exposure. It has been demonstrated that the
pollutant PCB153 exacerbates diet-induced obesity and
NAFLD in mice through alterations in adipokines and
disruptions in hepatic lipid metabolism (23). Additionally, high-fat diets appear to worsen arsenic-induced
liver fibrosis and inflammation (24), whereas diets high
in saturated fat appear to increase the toxicity and carcinogenic effects of POPs (25). Furthermore, the flame
retardant hexobromocyclododecane, was observed
to enhance high-fat diet-induced obesity and hepatic
steatosis and to impair glucose and lipid homeostasis
in mice (26).
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Cardiovascular diseases (CVDs) are the leading cause
of death worldwide, and it is estimated that approximately 90% of CVDs can be prevented (27). The primary
modifiable risk factors contributing to the development of
CVDs include poor dietary habits, physical inactivity, and
smoking (27). Similarly, to the development of obesity,
diets containing certain fatty acid profiles may promote
the development of CVDs. For example, consumption of
proinflammatory fatty acids such as linoleic and transfatty acids can contribute to endothelial cell dysfunction,
a beginning stage of atherosclerosis (19, 20). Additionally, it has been demonstrated, primarily in experimental
models, that exposure to environmental pollutants can
cause endothelial cell dysfunction and chronic inflammation and may contribute to the development of CVDs
(3, 28, 29). Furthermore, there is increasing experimental
evidence that poor nutrition and pollutant exposure can
interact and synergistically increase CVD risk (30). For
example, it has recently been shown that trimethylamine
N-oxide (TMAO), produced from the metabolism of dietary
carnitine or phosphatidyl choline, is a strong clinical biomarker of CVD (31–35). Interestingly, a recent preclinical
paper from our group found that dioxin-like pollutant
exposure increases the hepatic expression of the enzyme
flavin-containing monooxygenase (FMO3), which is critical for the production of TMAO. As such, this increase
in the hepatic expression of FMO3 resulted in increases
in circulating TMAO (36). Although this study was conducted in mice and the transcriptional regulation of FMO3
could differ in humans, this finding is important in that
it provides new evidence on how certain nutritional components and pollutants may interact to contribute to a
greater risk of CVD.
It is not surprising that pollutant exposure exhibits
detrimental combinatory effects with suboptimal nutrition as pollutants and nutritional components can target
the same molecular pathways, for example, the proinflammatory NF-κB pathway (4). However, this same idea
can be used from the perspective of nutrition as a protective modulator of pollutant toxicity and may be more
meaningful for those already exposed to high levels of
pollutants and exhibiting signs of chronic inflammatory
diseases.

Healthful nutrition can protect against the
health effects of pollutant exposure
It is well understood that a nutritious diet, rich in foods
containing bioactive food components such as polyphenols and anti-inflammatory fatty acids, can be protective
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against chronic inflammation, diabetes, metabolic syndrome, and CVD (16). Diets rich in these bioactive food
components often contain greater levels of antioxidant
and anti-inflammatory compounds and thus have the
capacity to attenuate the inflammatory and oxidative
properties of pollutant exposure. This paradigm has been
demonstrated consistently throughout the literature (37–
43). For example, we have shown that consumption of
polyphenol-rich green tea can decrease oxidative stress in
response to PCB 126 exposure and does so via upregulation of antioxidant enzymatic pathways (38). Additionally,
it has been observed that epigallocatechin gallate (EGCG),
a major polyphenol in green tea, can attenuate arsenicinduced cardiovascular inflammation and toxicity (42).
Resveratrol, a polyphenol found abundantly in fruits and
other plants, has been demonstrated to protect against
PCB-induced neuronal cell death as well as impairment in
adipocyte glucose homeostasis (44, 45).
Omega-3 polyunsaturated fatty acids, including
eicosapentaenoic acid and docosahexaenoic acid, found
abundantly in fatty fish and fish oil, exhibit potent antiinflammatory properties (46, 47). Indeed, individuals consuming a diet abundant in omega-3 fatty acids, such as
the well-studied Mediterranean diet, are documented as
having lower incidences of CVD, diabetes, and metabolic
syndrome (48). It is not surprising then, that experimental
evidence shows that omega-3 fatty acids can be protective against pollutant-induced inflammation and toxicity.
As such, we have demonstrated that omega-3 fatty acids
can protect against PCB-induced vascular endothelial cell
dysfunction (37), and others have shown that these fatty
acids can protect against pollutant-associated atherosclerotic plaque formation (49). Additionally, omega-3 fatty
acids appear to be protective against air pollutant-associated oxidative stress and cardiovascular complications
by increasing the activity of endogenous antioxidants and
decreasing lipoperoxidation (40, 43).
In addition to consuming a diet rich in polyphenols
and anti-inflammatory components, choosing to live an
active lifestyle may also protect against pollutant toxicity.
For example, a recent study by our laboratory observed
that exercise is capable of reducing inflammation and
CVD risk associated with PCB exposure (50). Furthermore, other groups have demonstrated that exercise can
attenuate PCB-associated alterations in the mouse gut
microbiome (51). This is an important finding because
the gut microbiome has recently been observed to regulate numerous health conditions, including obesity, CVD,
immune function, and neurological disorders (52–54).
Importantly, the gut microbiome is incredibly plastic and
can change rapidly in response to nutrition, exercise,
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and even pollutant exposure (52–54). Using nutrition
and exercise to combat pollutant-induced alterations in
the gut microbiome that may contribute to disease may
allow for important advances in therapeutic interventions and is a critical area of research that needs to be
further explored.
Because many of these environmental pollutants
are lipophilic and accumulate within the adipose tissue
of exposed individuals, examining nutritional means to
promote the excretion and reduction of body burden is an
important facet as well. It has been noted that individuals consuming a vegetarian or vegan diet trended towards
lower amounts of organochloride body burden (55).
However, it remains unclear whether this observation
was due to less exposure to contaminated foods (e.g. contaminated meats, fish, or dairy) or whether a plant-based
diets contain nutritional components that can promote
excretion of these pollutants. Although further research
is still warranted to examine nutritional means by which
to reduce pollutant body burden, some studies have indicated promising opportunities for therapeutic interventions in exposed individuals (56–58). Specifically, it has
been observed that consumption of olestra, a dietary fat
substitute, is effective at enhancing the excretion rate in
individuals exposed to high concentrations of PCBs and
is believed to do so through interference with the enterohepatic circulation of these pollutants (58–62). Because
olestra is no longer in production due to decreased popularity associated with adverse gastrointestinal side effects,
there is a need for research examining other dietary components that may alter enterohepatic circulation and/or
enhance pollutant excretion. As discussed, it is well documented that nutrition and lifestyle choices can both positively and negatively regulate pollutant toxicity. Recently,
the field of epigenetics has become important in furthering our understanding how environment and lifestyle
choices differentially influence gene expression and may
alter susceptibility to disease on an individual level.

Epigenetics as an emerging area
of pollutant toxicity research and
avenue for future intervention
Epigenetics overview
Epigenetics is a term given to describe all heritable
changes in gene expression that do not involve changes
within the genetic code (63). One of the most commonly

studied means of epigenetic modifications is DNA methylation, which involves the addition of a methyl group
to the five position of a cytosine. This modification most
often occurs on a cytosine-guanine dinucleotide (CpG).
CpG dinucleotides tend to be clustered in certain regions,
termed CpG islands, and are often located in the promoter
regions of protein-coding genes (63, 64). DNA methylation is involved in the regulation of numerous cellular
processes, ranging from chromosome stability, to X-chromosome inactivation, to gene transcription. Generally,
the hypermethylation of CpG islands within the promoter
regions results in gene silencing. Another common type
of epigenetic alteration includes histone modifications.
Histones are nuclear proteins that aid in the condensation of DNA into structural units called nucleosomes.
Histones can undergo posttranslational modifications
such as acetylation, methylation, and phosphorylation,
which affect the interactions of histones with the DNA and
associated nuclear proteins (63). Through these histone
modifications, alterations in chromatin structure and
subsequently gene expression are often observed (63, 64).
A third major type of epigenetic modification involves
microRNAs (miRNAs). miRNAs are small single-stranded
noncoding RNA molecules that when fully mature lead to
the degradation of target mRNA by direct binding. This
downregulation of target mRNAs can ultimately lead to
decreased protein production. miRNAs regulate numerous biological processes, and it has been observed that
alterations in miRNA expression are associated with the
development of diseases such as CVD, metabolic disorders and cancer (63–65).
Environment and lifestyle play critical roles in contributing to the epigenetic alterations discussed above
(65). Studies on monozygotic twin pairs have demonstrated that throughout the aging process, identical twins
develop differences in their epigenetic status despite their
common genetic makeup (63). These observations and the
knowledge that differences in epigenetic modifications
can play a role in disease contributed to increasing interest in examining the ways and extent to which our environment influences our epigenetic code.

Epigenetics, environmental exposures and
nutrition
It has been consistently demonstrated that exposure to
environmental pollutants can influence epigenetic modifications (65–69). Specifically, exposure to POPs can alter
the epigenetic code through several mechanisms. For
example, we have demonstrated that exposure to coplanar
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PCBs, including PCB 77 and PCB126, can induce vascular
endothelial cell dysfunction and inflammation through
alterations in histone modifications of the p65 subunit
of NF-κB that result in its increased activation (66). Additionally, we have shown that the commercial PCB mixture
Aroclor 1260 can upregulate miRNAs associated with
cardiac injury and inflammatory pathways in primary
human endothelial cells (69). In humans, it has been
observed that exposure to polyaromatic hydrocarbons
(PAH) results in alterations in specific miRNAs associated
with oxidative DNA damage and lipid peroxidation in coke
oven workers (67). Moreover, it was noted that exposure to
air pollution was associated with expression of miRNAs
that may mediate detrimental biological responses and
health effects (68).
One common theme with many pollutant-associated epigenetic alterations is that they induce modifications that contribute to proinflammatory and oxidative
pathways (65, 70). Interestingly, nutrition and positive
lifestyle choices can also contribute to epigenetic modifications that may combat these detrimental effects by
increasing antioxidant and anti-inflammatory responses
(71, 72). Polyphenolic compounds found in many fruits
and vegetables exhibit significant antioxidant and antiinflammatory capacities and thus are good candidates for
studies examining epigenetic means of protection against
pollutant toxicity. For example, curcumin, a component
found in turmeric that exhibits anti-inflammatory properties, has been observed to reduce histone acetylation
of the NF-κB coactivator p300 histone acetyltransferase
and thus suppress the activation of NF-κB (73). Similar
results were observed by our group with the tea catechin
EGCG (74). Furthermore, it has been reported that numerous polyphenols can activate SIRT1, a member of the
sirtuin family of histone deacetylases. When activated,
SIRT1 can participate in the deacetylation of transcription factors such as NF-κB, forkhead box class O (FoxO)
and p53, in turn modulating cellular pathways involved
in inflammation, metabolism, aging, and several other
conditions (71).
In addition to healthful nutrition, physical exercise
also contributes to epigenetic modifications that may
provide protection against metabolic, cardiovascular, and
other diseases. For example, one study found that acute
exercise resulted in changes in the methylation of the
promoter region of genes involved in energy and glucose
homeostasis, including pyruvate dehydrogenase kinase
isoenzyme 4 (PDK4), peroxisome proliferator-activated
receptor gamma coactivator 1-alpha (PCG1α), and peroxisome proliferator-activated receptor delta (PPARδ) within
skeletal muscle (75). Furthermore, physical exercise was
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observed to inhibit the miRNA miR-33 (76, 77). Cellular
effects of miR-33 inhibition involve the upregulation of
AMPK and subsequent increases in β-oxidation, which
may aid in balancing factors related to metabolic syndrome by increasing the breakdown of fatty acids from
adipose stores (77). The role of β-oxidation in metabolic
syndrome is complex and is influenced by both dietary
components and exercise, leading to an increase in fatty
acid oxidation and ultimately decreased obesity and
metabolic syndrome (78–80). Understanding the role of
miRNAs in lipid homeostasis may provide potential therapeutic strategies for reducing metabolic syndrome.
Although epigenetics can be modulated by healthful
nutrition and positive lifestyle choices, there is also evidence that epigenetics can be modified by poor nutrition.
Epidemiological data are very helpful at examining epigenetic alterations, as there appears to be inheritance to
specific DNA methylation patterns over generations. For
example, it has been shown that individuals who were
prenatally exposed to famine during the Dutch famine
(1940s) had reduced DNA methylation of the insulin-like
growth factor II (IGF2) gene six decades later, compared
to their siblings who were unexposed to the famine (81).
Also, it has been demonstrated that parental obesity can
alter DNA methylation patterns in imprinted genes of their
offspring, compared to offspring of nonobese parents,
and this is believed to increase the risk for the development of obesity and metabolic diseases later in life (82).
Although there is still much to be studied about the effects
of these alterations related to epigenetic modifications, it
is hypothesized that in both cases of undernutrition and
over-nutrition, the acquired epigenetic alterations may
be passed down to the subsequent generation and may
increase susceptibility to development of chronic diseases
throughout life (81–83).
The epigenetic alterations in response to nutrition and lifestyle choices have been well documented;
however, studies examining the epigenetic effects of
nutritional components on the modulation of pollutant toxicity are limited. A recent study conducted by our
group showed that EGCG, the most abundant polyphenol
found in green tea, can prevent against PCB126-induced
endothelial cell inflammation through epigenetic alterations of proinflammatory target genes of NF-κB (74). This
study was important in that it was one of the first studies
to indicate the epigenetic role of healthful nutrition in the
modulation of pollutant toxicity. Because of the gaps in
the literature regarding epigenetic regulation of pollutant
toxicity via nutritional and lifestyle interventions, there
is a great need for further research to formulate a better
understanding of this topic.
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Conclusion and future directions
Environmental pollutant exposure is associated with
numerous health complications ranging from cardiovascular disease, diabetes, and metabolic syndrome. There is
evidence that pollutant toxicity can be modulated by nutrition and lifestyle choices. Western diets, abundant in processed foods, excess caloric content and proinflammatory
fatty acids, may contribute to the development of obesity
and, cardiovascular diseases and can enhance pollutant
toxicity. Conversely, diets rich in bioactive food components, such as polyphenols and omega-3 fatty acids (i.e.
the Mediterranean diet), are associated with reduced risk
of inflammatory diseases and can attenuate the negative
health effects of pollutant exposure. Recently, epigenetics
has become a focus of both nutrition and pollutant research
and may provide a deeper mechanistic insight into how
these two environmental factors can interact. It has been
shown that both over- and undernutrition can contribute
to epigenetic modifications that are associated with an
increased risk of disease. Additionally, exposure to pollutants can alter epigenetic markers that may also contribute
to the development of health complications. Importantly,
we have shown that bioactive food components (e.g. EGCG)
can induce epigenetic alterations that attenuate inflammatory responses associated with PCB exposure and thus may
protect against the development atherosclerosis. Epigenetic marks differ for every individual, and therefore future
studies may allow us to understand how certain foods may
be used to alter specific epigenetic tags to reduce the risk
of pollutant-associated disease. Future studies also need to
focus on metabolites of both pollutants and nutrients and
the complex interplay of epigenetic regulation of chronic
diseases. Fostering an understanding at this detailed level
could help in developing personalized nutritional interventions that could epigenetically favor good health and thus
reduce the risk of disease.
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National Institute of Environmental Health Sciences at
the National Institutes of Health [P42ES007380], and the
University of Kentucky Agricultural Experiment Station.
Conflict of interests: The authors declare that there are no
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